Home›Companies›Healthcare›Vistim Labs

Vistim Labs Inc.

Develops brain monitoring software for clinicians caring for patients with cognitive impairment.

Updated Nov 19, 2026·Latest SEC filing Oct 22, 2024·Suggest an edit

About Vistim Labs

Vistim Labs is a private company based in Claymont, Delaware, incorporated in 2021 in Delaware. It has reported $932,000 raised in two offerings on Form D since January 2023. Its chief executive is James Hamet.

Funding Rounds (SEC Form D)

First saleFiled with SECAmount soldInvestorsAvg. checkTermsFiling
Sep 16, 2024Oct 22, 2024$125,000of $1.2M target1$125KEquityRule 506(b)Form D ↗
Dec 19, 2022Jan 3, 2023amended May 10, 2023$807,000of $810K target5$161KEquityRule 506(b)Form D/A ↗3 earlier filings
Total, two offerings$932,000

First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.

Leadership Team

Executive officers and directors listed on Vistim Labs's Form D filed Oct 22, 2024.

Frank Zanow
Frank Zanow
Board Director
On every Form D that Vistim Labs has filed: 5 filings, from Jan 3, 2023 to Oct 22, 2024.
James Hamet
James Hamet
Founder & CEO, director
On every Form D that Vistim Labs has filed: 5 filings, from Jan 3, 2023 to Oct 22, 2024.

Sources

  1. SECVistim Labs Inc. Form D/A, filed Mar 21, 2023
  2. SECVistim Labs Inc. Form D/A, filed Feb 15, 2023
  3. SECVistim Labs Inc. Form D, filed Jan 3, 2023
  4. SECVistim Labs Inc. filing history
  5. CompanyVistim Labs team
  6. PressHITLAB and Vistim Labs partnership